Skip to main content
Clinical Trials/NCT05274490
NCT05274490CompletedNot Applicable

Chronic Obstructive Pulmonary Disease Prognosis in Sars-covid 2 Infection

Sohag University1 site in 1 country100 target enrollmentStarted: June 1, 2021Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
100
Locations
1
Primary Endpoint
SOFA score measurement in both groups

Study Overview

Brief Summary

In this prospective observational study, patients were selected from attendees of the intensive care unit. Different measures and outcomes had been studied and compared between patients with and without COPD, including hospitalization, medical costs, length of Intensive care stay, respiratory failure, and death rate.

Study Design

Study Type
Observational
Observational Model
Case Control
Time Perspective
Prospective

Eligibility Criteria

Ages
20 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Age: more than 20 years old.
  • Both Males and females will be included.
  • COPD patients.
  • Recent confirmed the diagnosis with SARS-COV-2.

Exclusion Criteria

  • Pregnancy.
  • Malignancy.
  • Immunodeficiency disease

Outcomes

Primary Outcomes

SOFA score measurement in both groups

Time Frame: 2 weeks

monitoring of SOFA items along two weeks

Secondary Outcomes

  • prognosis of the disease(2 weeks)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Islam Mokhtar Ahmed

lecturer of anesthesia and intensive care

Sohag University

Study Sites (1)

Loading locations...

Similar Trials

COPD Prognosis in Covid Patients | Clinical Trial